Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.260, 2000-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Critical pathway cost saving for CAP management
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 250, 2000-01 ,pp. :
Access to resources
Recommend
Gatifloxacin-containing regimens cost saving in CAP
Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. :
Levofloxacin good choice in CAP
Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. :
Azithromycin + ceftriaxone as effective as levofloxacin for CAP
Inpharma, Vol. 1, Iss. 1473, 2005-01 ,pp. :
Levofloxacin reduces LOS and costs in CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 549, 2008-01 ,pp. :